Repligen Corp.

RGEN

Market Cap$9.25B

Close$

Compare Repligen

	P/E Ratio	Dividends	Return on Equity	Price-to-Sales	Debt-to-Equity
Repligen Corp.	222.5	0%	2%	14.4	0.3
Market Avg	58.9	1.29%	29%	-	1
Healthcare Avg	66.3	1.31%	15%	-	0.9

$65.51

Current Fair Value

58.6% downside

Overvalued by 58.6% based on the discounted cash flow analysis.

Share Statistics

Market cap	$9.25 Billion
Enterprise Value	$9.08 Billion
Dividend Yield	$0.0 (0.0%)
Earnings per Share	$0.74
Beta	0.0
Outstanding Shares	55,838,548
Avg 30 Day Volume	480,606

Return

Return on Equity	-
Return on Assets	-
Return on Invested Capital	-

Valuation & Multiples

P/E Ratio	222.48
PEG	-146.08
Price to Sales	14.4
Price to Book Ratio	4.52
Enterprise Value to Revenue	14.21
Enterprise Value to EBIT	378.16
Enterprise Value to Net Income	218
Total Debt to Enterprise	0.06
Debt to Equity	0.29

Revenue Sources

No data

ESG Score

No data

About Repligen Corp.

CEO: Anthony Hunt